Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (571-580 of 774) with videos related to

Pageof 78
Sort By:
The American Journal of Cardiology|May 15, 1993
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research GroupP B Berger, N A Ruocco, T J Ryan, et al.
International Journal of Cardiology|March 10, 2017
Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillationDarae Ko, Jonathan L Thigpen, James A Otis, et al.
The Canadian Journal of Cardiology|May 15, 2016
Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and HospitalEdward L Hannan, Michael J Racz, Gary Walford, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrelJuzar O Lokhandwala, Patricia J M Best, Joseph H Butterfield, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
Operative Dentistry|December 24, 2014
Effects of the concentration and composition of in-office bleaching gels on hydrogen peroxide penetration into the pulp chamberA P Mena-Serrano, S O Parreiras, E M S do Nascimento, et al.
JACC. Cardiovascular Interventions|May 21, 2016
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-AnalysisAsim M Rafique, Piyush Nayyar, Tracy Y Wang, et al.
Basic & Clinical Pharmacology & Toxicology|April 27, 2017
Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib TreatmentZinnia P Parra-Guillen, Peter B Berger, Manuel Haschke, et al.
Pageof 78

Showing results (571-580 of 774) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|May 15, 1993
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research GroupP B Berger, N A Ruocco, T J Ryan, et al.
International Journal of Cardiology|March 10, 2017
Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillationDarae Ko, Jonathan L Thigpen, James A Otis, et al.
The Canadian Journal of Cardiology|May 15, 2016
Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and HospitalEdward L Hannan, Michael J Racz, Gary Walford, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrelJuzar O Lokhandwala, Patricia J M Best, Joseph H Butterfield, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
Operative Dentistry|December 24, 2014
Effects of the concentration and composition of in-office bleaching gels on hydrogen peroxide penetration into the pulp chamberA P Mena-Serrano, S O Parreiras, E M S do Nascimento, et al.
JACC. Cardiovascular Interventions|May 21, 2016
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-AnalysisAsim M Rafique, Piyush Nayyar, Tracy Y Wang, et al.
Basic & Clinical Pharmacology & Toxicology|April 27, 2017
Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib TreatmentZinnia P Parra-Guillen, Peter B Berger, Manuel Haschke, et al.
Pageof 78